Cargando…

Beta Cell Dysfunction and Insulin Resistance

Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose s...

Descripción completa

Detalles Bibliográficos
Autor principal: Cerf, Marlon E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608918/
https://www.ncbi.nlm.nih.gov/pubmed/23542897
http://dx.doi.org/10.3389/fendo.2013.00037
_version_ 1782264287746588672
author Cerf, Marlon E.
author_facet Cerf, Marlon E.
author_sort Cerf, Marlon E.
collection PubMed
description Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose sensing to stimulate insulin secretion therefore elevated glucose concentrations prevail. Persistently elevated glucose concentrations above the physiological range result in the manifestation of hyperglycemia. With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective therefore hyperglycemia perseveres. Beta cell dysfunction supersedes insulin resistance in inducing diabetes. Both pathological states influence each other and presumably synergistically exacerbate diabetes. Preserving beta cell function and insulin signaling in beta cells and insulin signaling in the glucose recipient tissues will maintain glucose homeostasis.
format Online
Article
Text
id pubmed-3608918
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36089182013-03-29 Beta Cell Dysfunction and Insulin Resistance Cerf, Marlon E. Front Endocrinol (Lausanne) Endocrinology Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose sensing to stimulate insulin secretion therefore elevated glucose concentrations prevail. Persistently elevated glucose concentrations above the physiological range result in the manifestation of hyperglycemia. With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective therefore hyperglycemia perseveres. Beta cell dysfunction supersedes insulin resistance in inducing diabetes. Both pathological states influence each other and presumably synergistically exacerbate diabetes. Preserving beta cell function and insulin signaling in beta cells and insulin signaling in the glucose recipient tissues will maintain glucose homeostasis. Frontiers Media S.A. 2013-03-27 /pmc/articles/PMC3608918/ /pubmed/23542897 http://dx.doi.org/10.3389/fendo.2013.00037 Text en Copyright © 2013 Cerf. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Endocrinology
Cerf, Marlon E.
Beta Cell Dysfunction and Insulin Resistance
title Beta Cell Dysfunction and Insulin Resistance
title_full Beta Cell Dysfunction and Insulin Resistance
title_fullStr Beta Cell Dysfunction and Insulin Resistance
title_full_unstemmed Beta Cell Dysfunction and Insulin Resistance
title_short Beta Cell Dysfunction and Insulin Resistance
title_sort beta cell dysfunction and insulin resistance
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608918/
https://www.ncbi.nlm.nih.gov/pubmed/23542897
http://dx.doi.org/10.3389/fendo.2013.00037
work_keys_str_mv AT cerfmarlone betacelldysfunctionandinsulinresistance